These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3304207)

  • 1. Initiation and promotion in hepatocarcinogenesis.
    Schulte-Hermann R
    Arch Toxicol; 1987; 60(1-3):179-81. PubMed ID: 3304207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis.
    Lee GH
    Toxicol Pathol; 2000; 28(2):215-25. PubMed ID: 10805139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital as a promoter in the initiation/selection process of experimental rat hepatocarcinogenesis.
    Lans M; de Gerlache J; Taper HS; Préat V; Roberfroid MB
    Carcinogenesis; 1983; 4(2):141-4. PubMed ID: 6825204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor promotion in rat liver.
    Herren SL; Pereira MA
    Environ Health Perspect; 1983 Apr; 50():123-9. PubMed ID: 6135606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.
    Christensen JG; Romach EH; Healy LN; Gonzales AJ; Anderson SP; Malarkey DE; Corton JC; Fox TR; Cattley RC; Goldsworthy TL
    Carcinogenesis; 1999 Aug; 20(8):1583-90. PubMed ID: 10426811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
    Dragan YP; Singh J; Pitot HC
    Carcinogenesis; 1996 Sep; 17(9):2043-52. PubMed ID: 8824533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative aspects of chemical carcinogenesis and tumor promotion in liver.
    Kunz HW; Tennekes HA; Port RE; Schwartz M; Lorke D; Schaude G
    Environ Health Perspect; 1983 Apr; 50():113-22. PubMed ID: 6223810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical events in nitrosamine-induced hepatocarcinogenesis: relevance of animal data to human carcinogenesis.
    Schulte-Hermann R
    IARC Sci Publ; 1987; (84):17-9. PubMed ID: 3679361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
    Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
    Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
    Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
    Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of N-nitrosomorpholine and phenobarbital on UDP-glucuronyltransferase in putative preneoplastic foci of rat liver.
    Fischer G; Ulrich D; Bock KW
    Carcinogenesis; 1985 Apr; 6(4):605-9. PubMed ID: 2859128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of NNM-induced carcinogenesis in the rat liver by phenobarbital: a combined morphological and enzyme histochemical approach.
    Moore MA; Hacker HJ; Kunz HW; Bannasch P
    Carcinogenesis; 1983; 4(4):473-9. PubMed ID: 6132686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the expression of some genes for enzymes of glutathione metabolism in hepatotoxicity and hepatocarcinogenesis.
    Pitot HC; Goodspeed D; Dunn T; Hendrich S; Maronpot RR; Moran S
    Toxicol Appl Pharmacol; 1989 Jan; 97(1):23-34. PubMed ID: 2563599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinction of carcinogens from mutagens by induction of liver cell foci in a model for detection of initiation activity.
    Sakai H; Tsukamoto T; Yamamoto M; Kobayashi K; Yuasa H; Imai T; Yanai T; Masegi T; Tatematsu M
    Cancer Lett; 2002 Dec; 188(1-2):33-8. PubMed ID: 12406545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of multistage carcinogenesis in rat liver.
    Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
    Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of hepatocarcinogenesis in humans and animal models.
    Köhle C; Schwarz M; Bock KW
    Arch Toxicol; 2008 Sep; 82(9):623-31. PubMed ID: 18204979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Pogribny IP; Muskhelishvili L; Tryndyak VP; Beland FA
    Mutat Res; 2011 Jun; 722(2):106-13. PubMed ID: 20188851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a high-sucrose diet on the development of enzyme-altered foci in chemical hepatocarcinogenesis in rats.
    Hei TK; Sudilovsky O
    Cancer Res; 1985 Jun; 45(6):2700-5. PubMed ID: 2859110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.
    Pereira MA
    Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
    Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
    Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.